Skip to main content
Clinical Trials/NCT05722002
NCT05722002
Recruiting
Phase 4

Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial

University of Michigan15 sites in 2 countries900 target enrollmentFebruary 6, 2023

Overview

Phase
Phase 4
Intervention
Acetaminophen
Conditions
Surgery
Sponsor
University of Michigan
Enrollment
900
Locations
15
Primary Endpoint
Pain intensity based on Brief Pain Inventory (BPI) pain intensity score at the surgical site over 7 days post surgery
Status
Recruiting
Last Updated
15 days ago

Overview

Brief Summary

This trial is being completed to compare two commonly used options to treat pain after surgery. Participants that undergo gallbladder removal, hernia repair, and breast lump removal will be eligible to enroll. Eligible participants will be randomized to 1 of 2 groups of medications (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) plus acetaminophen or low dose opioids plus acetaminophen).

It is anticipated that the NSAID group will have superior clinical outcomes and fewer side effects when compared to the opioid group.

Registry
clinicaltrials.gov
Start Date
February 6, 2023
End Date
July 1, 2027
Last Updated
15 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mark Bicket, MD, PhD

Associate Professor

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • No significant analgesic medication use before surgery: For this study, significant analgesic medication use before surgery as use of prescriptions for opioid or NSAID medications in the past 30 days, or over-the-counter NSAID use on greater than 7 of 30 past days, as reported by the patient.
  • One of three common low-risk surgical procedures: For this study, the three-common low-risk surgical procedures will include laparoscopic gallbladder removal, inguinal hernia repair, and breast lumpectomy.

Exclusion Criteria

  • Anticipated other surgery within 6 months or anticipated life expectancy of less than 6 months
  • Patients with contraindications to NSAID drugs in the NSAID arm, opioid drugs in the OPIOID arm, or acetaminophen will be excluded. There are specific contraindications that will be reviewed per protocol.

Arms & Interventions

NSAID regimen

Surgical teams will elect for one of the medications within the treatment arm to which the patient is randomized.

Intervention: Acetaminophen

NSAID regimen

Surgical teams will elect for one of the medications within the treatment arm to which the patient is randomized.

Intervention: NSAID

Opioid regimen

Intervention: Opioid

Opioid regimen

Intervention: Acetaminophen

Outcomes

Primary Outcomes

Pain intensity based on Brief Pain Inventory (BPI) pain intensity score at the surgical site over 7 days post surgery

Time Frame: 7 days post surgery

This is a one question survey in which the worst pain intensity recorded (0-10 being the worst) will be used.

Safety outcome - number and severity of any adverse medication-related symptoms over 7 days post surgery

Time Frame: 7 days post surgery

Symptom Checklist will proactively screen patients for reports of adverse events from analgesic medications over the first 7 days post surgery.

Secondary Outcomes

  • Patient Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance v1.0 4a questionnaire(1 month post surgery)
  • Patient Global Impression of Change (PGIC)(up to 1 month after surgery)
  • Quality of Recovery (QoR) 15(7 days post surgery)
  • PROMIS Pain Interference 4a(3 months)
  • New prolonged opioid use(days 4-180 post surgery)
  • Chronic pain based on Brief Pain Inventory (BPI) pain intensity score at 180 days post surgery(180 days post surgery)
  • Chronic pain based on Body Map(180 days post surgery)
  • Acute pain based on The Michigan Body Map(7 days post surgery)
  • Healthcare Utilization related to pain at 1 month(within 1 months after surgery)
  • PROMIS Preference score 29+2 Profile v2.1(3 months)
  • Substance use based on the Tobacco, Alcohol, Prescription medications, and other Substance (TAPS) tool(180 days post surgery)
  • National Survey on Drug Use and Health Questions (NSDUH) on Opioid Misuse opioid misuse question(180 days)
  • Clinically important adverse events(180 days post surgery)
  • Healthcare Utilization related to pain at 6 months(within 6 months after surgery)
  • Quality of Recovery (QoR) 15(3 days post surgery)
  • National Survey on Drug Use and Health Questions (NSDUH) on Opioid Misuse opioid misuse question(3 months)

Study Sites (15)

Loading locations...

Similar Trials